BioMicroCenter:Nextera: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
-- under construction-- | -- under construction-- | ||
Nextera DNA sample preparation for Illumina sequencing from Epicentre technologies uses a modified transposase to simultaneously fragment and tag intact genomic DNA. A limited number of PCR steps are needed to create complete | Nextera DNA sample preparation for Illumina sequencing from Epicentre technologies uses a modified transposase to simultaneously fragment and tag intact genomic DNA. A limited number of PCR steps are needed to create complete Illumina libraries. | ||
[[Image:I_Nextera_Illumina_fig1.gif|left|400px]] | [[Image:I_Nextera_Illumina_fig1.gif|left|400px]] | ||
Nextera samples prepared in parallel with SPRI- | Nextera samples prepared in parallel with SPRI-prepared Illumina libraries provided a similar quality of sequencing data. DNA from the same Colobacter DNA sample was either sonicated for SPRI-prep or provided as intact DNA for Nextera prep. The samples were multiplexed and sequenced together on an Illumina GAII 40bp single-end lane. The total genomic coverage for both Nextera and SPRI-te samples was exactly the same at 97.8% coverage of Colobacter’s GC-rich genome, although complexity was greater in the sonicated samples. | ||
[[Image:Nextera_2.png|center|550px]] | [[Image:Nextera_2.png|center|550px]] | ||
The | The Nextera transposase does exhibit a mild GC-insertion bias, shown by the increase in percent of the first few bases. This, however, did not affect the sequencing coverage. The Nextera-prepared sample has very consistent genome-wide coverage, while the SPRI-prepared samples have a more variable coverage density. | ||
[[Image:Nextera_3.png]] [[Image:Nextera_4.png|300px]] | [[Image:Nextera_3.png]] [[Image:Nextera_4.png|300px]] | ||
We have used Nextera DNA sample preparation for multiple samples and have | We have used Nextera DNA sample preparation for multiple samples and have seen high-quality data for all the samples. Below is an example of a CNV study prepared with Nextera DNA preparation. | ||
[[Image:CNV_data_example.png|center|600px]] | [[Image:CNV_data_example.png|center|600px]] |
Revision as of 09:06, 29 September 2011
-- under construction--
Nextera DNA sample preparation for Illumina sequencing from Epicentre technologies uses a modified transposase to simultaneously fragment and tag intact genomic DNA. A limited number of PCR steps are needed to create complete Illumina libraries.
Nextera samples prepared in parallel with SPRI-prepared Illumina libraries provided a similar quality of sequencing data. DNA from the same Colobacter DNA sample was either sonicated for SPRI-prep or provided as intact DNA for Nextera prep. The samples were multiplexed and sequenced together on an Illumina GAII 40bp single-end lane. The total genomic coverage for both Nextera and SPRI-te samples was exactly the same at 97.8% coverage of Colobacter’s GC-rich genome, although complexity was greater in the sonicated samples.
The Nextera transposase does exhibit a mild GC-insertion bias, shown by the increase in percent of the first few bases. This, however, did not affect the sequencing coverage. The Nextera-prepared sample has very consistent genome-wide coverage, while the SPRI-prepared samples have a more variable coverage density.
We have used Nextera DNA sample preparation for multiple samples and have seen high-quality data for all the samples. Below is an example of a CNV study prepared with Nextera DNA preparation.